Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?

This publication has 78 references indexed in Scilit:

• Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study
  The American Journal of Cardiology, 2004
• Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)
  American Heart Journal, 2003
• European guidelines on cardiovascular disease prevention in clinical practice
  Atherosclerosis, 2003
• The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
  The American Journal of Cardiology, 1999
• Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease
  PharmacoEconomics, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Marginal Likelihood from the Gibbs Output
  Journal of the American Statistical Association, 1995
• Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
  The American Journal of Cardiology, 1991
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality
  Journal of Chronic Diseases, 1978